MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7326/annals-24-01631

Медицинская библиотека · Annals of internal medicine · 2025

The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months : A Randomized Clinical Trial.

Catenacci Victoria A, Ostendorf Danielle M, Pan Zhaoxing, Kaizer Laura K, Creasy Seth A, Zaman Adnin, Caldwell Ann E, Dahle Jared, Swanson Bryan, Breit Matthew J, Bing Kristen, Wayland Liza T, Panter Shelby L, Scorsone Jared J, Bessesen Daniel H, MacLean Paul, Melanson Edward L

СтатьяРандомизированное исследованиеСравнительное исследованиеПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

BACKGROUND

Long-term (≥12 months) randomized trials evaluating the efficacy of intermittent fasting (IMF) as a dietary weight loss strategy are limited. Furthermore, no studies have compared IMF versus daily caloric restriction (DCR) when both interventions are provided in the context of a guidelines-based behavioral weight loss program.

OBJECTIVE

To compare the effects of 4:3 IMF versus DCR on changes in weight at 12 months, with comprehensive behavioral support provided to both groups.

DESIGN

Randomized clinical trial. (ClinicalTrials.gov: NCT03411356).

SETTING

Denver, Colorado, and surrounding metropolitan area.

PARTICIPANTS

Adults aged 18 to 60 years with body mass index (BMI) of 27 to 46 kg/m2.

INTERVENTION: The IMF group was instructed to restrict energy intake by 80% on 3 nonconsecutive days per week, with ad libitum intake (no restriction) the other 4 days (4:3 IMF). The DCR group was instructed to reduce daily energy intake by 34% to match the weekly energy deficit of 4:3 IMF. Both groups received a high-intensity comprehensive behavioral weight loss program that included group-based behavioral support and a recommendation to increase moderate-intensity physical activity to 300 minutes per week.

MEASUREMENTS: The primary outcome was change in body weight (in kilograms) at 12 months.

RESULTS

Of the 165 (4:3 IMF, n = 84; DCR, n = 81) randomly assigned participants (mean age, 42 years [SD, 9]; mean BMI, 34.1 kg/m2 [SD, 4.4]; 73.9% female), 125 completed the trial. In an intention-to-treat analysis, 4:3 IMF showed greater reductions in weight than DCR at 12 months (mean difference, 2.89 kg [95% CI, 5.65 to 0.14 kg]; P = 0.040).

LIMITATION: Limited generalizability.

CONCLUSION

Compared with DCR, 4:3 IMF resulted in modestly greater weight loss among adults with overweight or obesity enrolled in a 12-month, high-intensity, comprehensive behavioral weight loss program.

PRIMARY FUNDING SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases.

Для цитирования: Catenacci Victoria A, Ostendorf Danielle M, Pan Zhaoxing, Kaizer Laura K, Creasy Seth A, Zaman Adnin, Caldwell Ann E, Dahle Jared, Swanson Bryan, Breit Matthew J, Bing Kristen, Wayland Liza T, Panter Shelby L, Scorsone Jared J, Bessesen Daniel H, MacLean Paul, Melanson Edward L. The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months : A Randomized Clinical Trial.. Annals of internal medicine. 2025. DOI: 10.7326/annals-24-01631.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.